Dusa Pharmaceuticals, Inc. (DUSA) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Dusa Pharmaceuticals, Inc. Company Snapshot

Business Description:

Dusa Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company that is developing and marketing Levulan photodynamic therapy (Levulan PDT), and other products for common skin conditions. The Company's marketed products include Levulan Kerastick 20% Topical Solution with PDT, the BLU-U brand light source, and ClindaReach. The Levulan Kerastick 20% Topical Solution with PDT and the BLU-U were launched for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp. AKs are precancerous skin lesions caused by chronic sun exposure that can develop over time into a form of skin cancer called squamous cell carcinoma. The Company operates in two segments, Photodynamic Therapy (PDT) Drug and Device Products and Non-Photodynamic Therapy (Non-PDT) Drug Products. In our complete report available for purchase the company is compared to: Ligand Pharmaceuticals Inc, Vanda Pharmaceuticals Inc. and Integrated Biopharma, Inc..

Dusa Pharmaceuticals, Inc.

Stock Performance Chart for Dusa Pharmaceuticals, Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 4.69
(Figures in U.S. Dollars)

1 Week	-6.2%		13 Weeks	4.0%

4 Weeks	33.2%		52 Weeks	56.9%

Dusa Pharmaceuticals, Inc. Key Data:

	Ticker:	DUSA	Country:	UNITED STATES

	Exchanges:	NAS	Major Industry:	Drugs, Cosmetics & Health Care

			Sub Industry:	Ethical Drug Manufacturers

	2010 Sales	37,432,998 (Year Ending Jan 2011).	Employees:	86

	Currency:	U.S. Dollars	Market Cap:	115,605,517

	Fiscal Yr Ends:	December	Shares Outstanding:	24,649,364

	Share Type:	Common	Closely Held Shares:	4,349,891

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.